INDAPAMIDE Side Effects

7022461-4 | Blood Creatinine Increased, Extrasystoles, Loss Of Consciousness, Malaise, Orthostatic Hypotension
on Sep 22, 2010 Male patient from FRANCE , 86 years of age, was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, extrasystoles, loss of consciousness, malaise, orthostatic hypotension. Indapamide dosage: . During the same period patient was treated with SOTALEX (View Sotalex Review and Sotalex Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), VALPROATE MAGNESIUM (View Valproate Magnesium Review and Valproate Magnesium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), FLUTICASONE PROPIONATE/SALMETEROL XINAFOATE (View Fluticasone Propionate/salmeterol Xinafoate Review and Fluticasone Propionate/salmeterol Xinafoate Label ), INIPOMP (View Inipomp Review and Inipomp Label ).

7020675-0 | Leukopenia, Neutropenia
Patient was taking Indapamide (View Usage). Patient had the following side effects: leukopenia, neutropenia on Sep 24, 2010 from FRANCE Additional patient health information: Male patient , 55 years of age, weighting 158.7 lb, was diagnosed with hypertension and. Indapamide dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), ANTIPSYCHOTICS (View Antipsychotics Review and Antipsychotics Label ), ORAL ANTIDIABETICS (View Oral Antidiabetics Review and Oral Antidiabetics Label ), ANALGESICS (View Analgesics Review and Analgesics Label ).

7014173-8 | Chest Discomfort, Dyspnoea, Hyponatraemia
Adverse event was reported on Sep 24, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: 1.25 Mg Daily Po) . Location: UNITED STATES , 79 years of age, After Indapamide was administered, patient had the following side effects: chest discomfort, dyspnoea, hyponatraemia. Patient was hospitalized.

6980642-X | Blood Cholesterol Increased, Blood Pressure Increased, Cerebral Haemorrhage, Cerebrovascular Accident, Malaise, Muscular Weakness, Thyroid Cancer, Transient Ischaemic Attack, Visual Impairment
on Aug 31, 2010 Female patient from UNITED KINGDOM , 63 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood pressure increased, cerebral haemorrhage, cerebrovascular accident, malaise, muscular weakness, thyroid cancer (What is thyroid cancer?), transient ischaemic attack, visual impairment. Indapamide dosage: 1.5 Mg: Qd;. During the same period patient was treated with COZAAR (100 Mg; Qd; Po) (View Cozaar Review and Cozaar Label ), METFORMIN (View Metformin Review and Metformin Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.


6972004-6 | Gout
on Sep 08, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was treated with Indapamide (View Usage). Patient had the following side effects: gout (What is gout?). Indapamide dosage: 1.25 Mg 1 A Day 3-4 Days 2nd Time 3 Days.

6941408-X | Diarrhoea, Fall, Hypokalaemia, Hyponatraemia
Patient was taking Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: diarrhoea, fall (What is fall?), hypokalaemia, hyponatraemia on Aug 11, 2010 from FRANCE Additional patient health information: Female patient , 87 years of age, was diagnosed with hypertension, depression (What is depression?), constipation (What is constipation?) and. Indapamide dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), FORLAX (View Forlax Review and Forlax Label ), PROPOFAN (View Propofan Review and Propofan Label ), ACTONEL (View Actonel Review and Actonel Label ), IDEOS (View Ideos Review and Ideos Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6941407-8 | Diarrhoea, Fall, Hypokalaemia, Hyponatraemia
Adverse event was reported on Aug 11, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension, depression (What is depression?), constipation (What is constipation?) and. Location: FRANCE , 87 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, fall (What is fall?), hypokalaemia, hyponatraemia. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), FORLAX (View Forlax Review and Forlax Label ), PROPOFAN (View Propofan Review and Propofan Label ), ACTONEL (View Actonel Review and Actonel Label ), IDEOS (View Ideos Review and Ideos Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6941405-4 | Diarrhoea, Fall, Hypokalaemia, Hyponatraemia
on Aug 11, 2010 Female patient from FRANCE , 87 years of age, was diagnosed with hypertension, depression (What is depression?), constipation (What is constipation?) and was treated with Indapamide (View Usage). Patient had the following side effects: diarrhoea, fall (What is fall?), hypokalaemia, hyponatraemia. Indapamide dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), FORLAX (View Forlax Review and Forlax Label ), PROPOFAN (View Propofan Review and Propofan Label ), ACTONEL (View Actonel Review and Actonel Label ), IDEOS (View Ideos Review and Ideos Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6941404-2 | Diarrhoea, Fall, Hypokalaemia, Hyponatraemia
on Aug 11, 2010 Female patient from FRANCE , 87 years of age, was diagnosed with hypertension, depression (What is depression?), constipation (What is constipation?) and was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: diarrhoea, fall (What is fall?), hypokalaemia, hyponatraemia. Indapamide dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), FORLAX (View Forlax Review and Forlax Label ), PROPOFAN (View Propofan Review and Propofan Label ), ACTONEL (View Actonel Review and Actonel Label ), IDEOS (View Ideos Review and Ideos Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6940151-0 | Lichenoid Keratosis
Patient was taking Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis on Aug 11, 2010 from ROMANIA Additional patient health information: Female patient , 51 years of age, was diagnosed with hypertension, diabetes mellitus and. Indapamide dosage: . During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SALAZOPYRIN (2 G, Unk) (View Salazopyrin Review and Salazopyrin Label ), INFLIXIMAB (5 Mg/kg, Unk) (View Infliximab Review and Infliximab Label ), LEFLUNOMIDE (10 Mg, Unk) (View Leflunomide Review and Leflunomide Label ), METFORMIN (View Metformin Review and Metformin Label ).

6930438-X | Face Oedema, Hyponatraemia, Myalgia, Oedema Peripheral
Adverse event was reported on Aug 06, 2010 by a Male patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 66 years of age, weighting 145.5 lb, Patient had the following side effects: face oedema, hyponatraemia, myalgia, oedema peripheral. During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), MICARDIS (View Micardis Review and Micardis Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ROCORNAL (View Rocornal Review and Rocornal Label ). Patient was hospitalized.

6900645-0 | Anaemia, Cardiac Arrest, Convulsion, Fall, Head Injury, Hypophagia, Nausea, Pyrexia, Thrombocytopenia
on Jul 19, 2010 Male patient from DENMARK , 71 years of age, was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: anaemia, cardiac arrest (What is cardiac arrest?), convulsion, fall (What is fall?), head injury, hypophagia, nausea (What is nausea?), pyrexia, thrombocytopenia. Indapamide dosage: 2.5 Mg; Qd; Po. During the same period patient was treated with TETANUS TOXOID (TETANUS TOXOID) (View Tetanus Toxoid (tetanus Toxoid) Review and Tetanus Toxoid (tetanus Toxoid) Label ), METHYLPREDNISOLONE (40 Mg) (View Methylprednisolone Review and Methylprednisolone Label ), HYCAMTIN (3.6 Mg; Qd; Iv) (View Hycamtin Review and Hycamtin Label ), CEFTAZIDIME PENTAHYDRATE (View Ceftazidime Pentahydrate Review and Ceftazidime Pentahydrate Label ), DIAZEPAM (10 Mg; Iv) (View Diazepam Review and Diazepam Label ), NORVASC (5 Mg; Qd; Po) (View Norvasc Review and Norvasc Label ), ENALAPRIL MALEATE (20 Mg; Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), DIFLUCAN (50 Mg; Qd) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

6860309-9 | Myocardial Infarction
on Jul 12, 2010 Female patient from FRANCE , 73 years of age, weighting 187.4 lb, was diagnosed with hypertension, osteoporosis (What is osteoporosis?), pain (What is pain?) and was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Indapamide dosage: . During the same period patient was treated with STRONTIUM RANELATE (View Strontium Ranelate Review and Strontium Ranelate Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

6860293-8 | Fall, Hypokalaemia, Rhabdomyolysis
Patient was taking Indapamide (View Usage). Patient had the following side effects: fall (What is fall?), hypokalaemia, rhabdomyolysis on Jul 09, 2010 from FRANCE Additional patient health information: Male patient , 71 years of age, . Indapamide dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), TRIMETAZIDINE HYDROCHLORIDE (View Trimetazidine Hydrochloride Review and Trimetazidine Hydrochloride Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TRIMEPRAZINE TAB (View Trimeprazine Tab Review and Trimeprazine Tab Label ). Patient was hospitalized.

6859775-4 | Lichenoid Keratosis
Adverse event was reported on Jul 06, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: ) . Location: ROMANIA , 51 years of age, After Indapamide was administered, patient had the following side effects: lichenoid keratosis. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SULFASALAZINE (2 G, Unk) (View Sulfasalazine Review and Sulfasalazine Label ), INFLIXIMAB (5 Mg/kg, Unk) (View Infliximab Review and Infliximab Label ), LEFLUNOMIDE (10 Mg, Unk) (View Leflunomide Review and Leflunomide Label ).

6843995-9 | Asthenia, Fall, Hyponatraemia, Renal Failure Chronic
on Jul 14, 2010 Female patient from UNITED STATES , 94 years of age, weighting 184.1 lb, was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, fall (What is fall?), hyponatraemia, renal failure chronic. Indapamide dosage: 1.25 Mg Daily Po, Prior To Admit. During the same period patient was treated with INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6826483-5 | Angle Closure Glaucoma
on Jun 30, 2010 Female patient from INDIA , 53 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient had the following side effects: angle closure glaucoma. Indapamide dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), INSULIN (View Insulin Review and Insulin Label ).

6820024-4 | Confusional State, Haematuria, Hyponatraemia
Patient was taking Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: confusional state, haematuria, hyponatraemia on Jun 30, 2010 from FRANCE Additional patient health information: Female patient , 83 years of age, weighting 123.5 lb, was diagnosed with hypertension, thrombosis prophylaxis and. Indapamide dosage: . During the same period patient was treated with ASPIRINE (View Aspirine Review and Aspirine Label ), FRAXIPARIN (View Fraxiparin Review and Fraxiparin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CELECTOL (View Celectol Review and Celectol Label ), TRIATEC (View Triatec Review and Triatec Label ), OMIX (View Omix Review and Omix Label ), PLAVIX (View Plavix Review and Plavix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6820016-5 | Visual Impairment
Adverse event was reported on Jul 01, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED KINGDOM , 64 years of age, Patient experienced the following unwanted or unexpected effects: visual impairment. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6818715-4 | Accident, Blood Calcium Decreased, Blood Cholesterol Increased, Blood Pressure Increased, Blood Triglycerides Increased, Pharyngeal Mass, Thyroid Disorder, Vascular Rupture, Visual Impairment
on Jun 18, 2010 Female patient from UNITED KINGDOM , 56 years of age, was treated with Indapamide (View Usage). Patient had the following side effects: accident, blood calcium decreased, blood cholesterol increased, blood pressure increased, blood triglycerides increased, pharyngeal mass, thyroid disorder, vascular rupture, visual impairment. Indapamide dosage: 1.5 Mg; Qd;. During the same period patient was treated with COZAAR (CON.) (View Cozaar (con.) Review and Cozaar (con.) Label ), METFORMIN (CON.) (View Metformin (con.) Review and Metformin (con.) Label ). Patient was hospitalized.

6812103-2 | Erythema Multiforme, Haemodialysis, Hypotension
on Jun 22, 2010 Male patient from DENMARK , 56 years of age, was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: erythema multiforme, haemodialysis, hypotension. Indapamide dosage: 2.5 Mg. During the same period patient was treated with RANITIDINE (150 Mg;bid) (View Ranitidine Review and Ranitidine Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

6769676-8 | Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Jun 07, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, . Indapamide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), REMICADE (Once Every Two Months) (View Remicade Review and Remicade Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

6760185-9 | Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on May 28, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: SPAIN , 84 years of age, Patient had the following side effects: inappropriate antidiuretic hormone secretion. During the same period patient was treated with ANAFRANIL (View Anafranil Review and Anafranil Label ), SOMAZINA (View Somazina Review and Somazina Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BETAGAN (View Betagan Review and Betagan Label ). Patient was hospitalized.

6733613-2 | Blood Potassium Decreased, Primary Hyperaldosteronism, Syncope, Torsade De Pointes
on May 11, 2010 Female patient from CZECH REPUBLIC , 42 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: blood potassium decreased, primary hyperaldosteronism, syncope, torsade de pointes. Indapamide dosage: . Patient was hospitalized.

6727548-9 | Blood Pressure Increased, Haemorrhagic Stroke, Visual Impairment
on May 11, 2010 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, haemorrhagic stroke, visual impairment. Indapamide dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6710114-9 | Blood Pressure Increased, Cerebral Haemorrhage, Cerebrovascular Accident, Visual Impairment
Patient was taking Indapamide (View Usage). Patient had the following side effects: blood pressure increased, cerebral haemorrhage, cerebrovascular accident, visual impairment on Apr 26, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, weighting 191.8 lb, was diagnosed with hypertension and. Indapamide dosage: . During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ). Patient was hospitalized.

6698471-3 | Angioedema, Dysphagia, Localised Oedema, Tongue Oedema
Adverse event was reported on Apr 15, 2010 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension, ischaemic cardiomyopathy, goitre, type 2 diabetes mellitus and. Location: FRANCE , 89 years of age, After Indapamide was administered, patient had the following side effects: angioedema, dysphagia, localised oedema, tongue oedema. During the same period patient was treated with COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ), CALCIUM CARBONATE/MAGNESIUM CARBONATE/MENTHA X PIPERITA OIL (View Calcium Carbonate/magnesium Carbonate/mentha X Piperita Oil Review and Calcium Carbonate/magnesium Carbonate/mentha X Piperita Oil Label ), TAHOR (View Tahor Review and Tahor Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ATARAX (View Atarax Review and Atarax Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

6665580-4 | Asthenia, Hyperkalaemia, Hyponatraemia
on Mar 25, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hyperkalaemia, hyponatraemia. Indapamide dosage: Dose:1 Unit(s). During the same period patient was treated with PERINDOPRIL (Dose:1 Unit(s)) (View Perindopril Review and Perindopril Label ), ALDACTONE (Dose:1 Unit(s)) (View Aldactone Review and Aldactone Label ), ADVIL (View Advil Review and Advil Label ), IXPRIM (View Ixprim Review and Ixprim Label ), FLECTOR (View Flector Review and Flector Label ). Patient was hospitalized.

6602298-8 | Coma, Heart Rate Decreased, Hypokalaemia, Hypotension, Intentional Overdose, Polyuria, Sinus Tachycardia, Suicide Attempt
on Feb 11, 2010 Male patient from HONG KONG , 89 years of age, was diagnosed with suicide attempt and was treated with Indapamide (View Usage). Patient had the following side effects: coma, heart rate decreased, hypokalaemia, hypotension, intentional overdose, polyuria, sinus tachycardia, suicide attempt. Indapamide dosage: . During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6602297-6 | Coma, Hypokalaemia, Hypotension, Intentional Overdose, Polyuria, Sinus Tachycardia
Patient was taking Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: coma, hypokalaemia, hypotension, intentional overdose, polyuria, sinus tachycardia on Feb 11, 2010 from HONG KONG Additional patient health information: Male patient , 89 years of age, was diagnosed with suicide attempt and. Indapamide dosage: . During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6602296-4 | Coma, Hypokalaemia, Hypotension, Intentional Overdose, Polyuria, Sinus Tachycardia
Adverse event was reported on Feb 11, 2010 by a Male patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with suicide attempt and. Location: HONG KONG , 89 years of age, Patient experienced the following unwanted or unexpected effects: coma, hypokalaemia, hypotension, intentional overdose, polyuria, sinus tachycardia. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6547297-X | Pemphigoid
on Apr 20, 2009 Female patient from GREECE , 84 years of age, was treated with Indapamide (View Usage). Patient had the following side effects: pemphigoid. Indapamide dosage: . During the same period patient was treated with PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6539227-1 | Confusional State, Hypokalaemia, Hyponatraemia, Rhabdomyolysis
on Dec 29, 2009 Female patient from ITALY , 60 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: confusional state, hypokalaemia, hyponatraemia, rhabdomyolysis. Indapamide dosage: . During the same period patient was treated with EUTIROX (View Eutirox Review and Eutirox Label ).

6537922-1 | Decreased Appetite, Dehydration, Hyponatraemia, Osteoarthritis, Renal Failure, Urinary Retention, Urinary Tract Infection
Patient was taking Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dehydration, hyponatraemia, osteoarthritis (What is osteoarthritis?), renal failure, urinary retention, urinary tract infection (What is urinary tract infection?) on Dec 30, 2009 from FRANCE Additional patient health information: Female patient , 91 years of age, was diagnosed with hypertension and. Indapamide dosage: . During the same period patient was treated with ZALDIAR (View Zaldiar Review and Zaldiar Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), CETORNAN (View Cetornan Review and Cetornan Label ), APROVEL (View Aprovel Review and Aprovel Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6537884-7 | Altered State Of Consciousness, Blood Creatine Phosphokinase Increased, Hyponatraemia, Musculoskeletal Stiffness
Adverse event was reported on Dec 29, 2009 by a Male patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 73 years of age, Patient had the following side effects: altered state of consciousness, blood creatine phosphokinase increased, hyponatraemia, musculoskeletal stiffness. During the same period patient was treated with EPLERENONE (View Eplerenone Review and Eplerenone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), LASIX (View Lasix Review and Lasix Label ), ITAVASTATIN (View Itavastatin Review and Itavastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NITOROL (View Nitorol Review and Nitorol Label ). Patient was hospitalized.

6528926-3 | Erythema Multiforme
on Dec 11, 2009 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with cerebrovascular accident, prophylaxis and was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: erythema multiforme. Indapamide dosage: 2.5 Mg; Qam;po. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), GALANTAMINE HYDROBROMIDE (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ).

6522773-4 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
on Dec 15, 2009 Female patient from GREECE , 67 years of age, was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes. Indapamide dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ). Patient was hospitalized.

6522772-2 | Cardiac Arrest, Torsade De Pointes
Patient was taking Indapamide (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), torsade de pointes on Dec 15, 2009 from GREECE Additional patient health information: Female patient , 42 years of age, . Indapamide dosage: . Patient was hospitalized.

6517740-0 | Bradycardia, Nausea
Adverse event was reported on Dec 14, 2009 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: GERMANY , 83 years of age, After Indapamide was administered, patient had the following side effects: bradycardia, nausea (What is nausea?). During the same period patient was treated with DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), HUMAN ACTRAPHANE (View Human Actraphane Review and Human Actraphane Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SORTIS ^PARKE DAVIS^ (View Sortis ^parke Davis^ Review and Sortis ^parke Davis^ Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ). Patient was hospitalized.

6517739-4 | Bradycardia, Nausea
on Dec 14, 2009 Female patient from GERMANY , 83 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, nausea (What is nausea?). Indapamide dosage: . During the same period patient was treated with DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), HUMAN ACTRAPHANE (View Human Actraphane Review and Human Actraphane Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SORTIS ^PARKE DAVIS^ (View Sortis ^parke Davis^ Review and Sortis ^parke Davis^ Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ). Patient was hospitalized.

6449724-5 | Altered State Of Consciousness, Blood Creatine Phosphokinase Increased, Hyponatraemia, Musculoskeletal Stiffness
on Nov 12, 2009 Male patient from JAPAN , 73 years of age, was diagnosed with hypertension and was treated with Indapamide (View Usage). Patient had the following side effects: altered state of consciousness, blood creatine phosphokinase increased, hyponatraemia, musculoskeletal stiffness. Indapamide dosage: . Patient was hospitalized.

6443270-0 | Altered State Of Consciousness, Blood Creatine Phosphokinase Increased, Hyponatraemia, Musculoskeletal Stiffness
Patient was taking Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: altered state of consciousness, blood creatine phosphokinase increased, hyponatraemia, musculoskeletal stiffness on Nov 12, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hypertension and. Indapamide dosage: . Patient was hospitalized.

6359420-0 | Erythema, Photosensitivity Reaction, Pruritus, Rash
Adverse event was reported on Sep 03, 2009 by a Female patient taking Indapamide (View Usage) (Dosage: ) was diagnosed with blood pressure increased, hypothyroidism and. Location: UNITED KINGDOM , 51 years of age, weighting 377.0 lb, Patient experienced the following unwanted or unexpected effects: erythema, photosensitivity reaction, pruritus, rash (What is rash?). During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6208225-X | Ejection Fraction Decreased, Electrocardiogram Qt Prolonged, Torsade De Pointes
on May 11, 2009 Female patient from GREECE , 67 years of age, was treated with Indapamide (View Usage). Patient had the following side effects: ejection fraction decreased, electrocardiogram qt prolonged, torsade de pointes. Indapamide dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ).

6208224-8 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
on May 11, 2009 Female patient from GREECE , 42 years of age, was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes. Indapamide dosage: .

6207855-9 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
Patient was taking Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes on May 11, 2009 from GREECE Additional patient health information: Female patient , 67 years of age, . Indapamide dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ).

6207854-7 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
Adverse event was reported on May 11, 2009 by a Female patient taking Indapamide (View Usage) (Dosage: ) . Location: GREECE , 42 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes.

6197508-8 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
on May 12, 2009 Female patient from GREECE , 67 years of age, was treated with Indapamide (View Usage). After Indapamide was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes. Indapamide dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ). Patient was hospitalized.

6196715-8 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
on May 07, 2009 Female patient from GREECE , 42 years of age, was treated with Indapamide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes. Indapamide dosage: .

6182852-0 | Renal Failure Acute, Stevens-johnson Syndrome
Patient was taking Indapamide (View Usage). Patient had the following side effects: renal failure acute, stevens-johnson syndrome on Apr 24, 2009 from SPAIN Additional patient health information: Male patient , 62 years of age, was diagnosed with hypertension and. Indapamide dosage: . Patient was hospitalized.